Bernard Osero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bernard Osero has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adrienne F. A. Meyers
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada
1 shared publication - Charles Wachihi
Kenya AIDS Control Program, Nairobi, Kenya
1 shared publication - Elijah Songok
Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada
1 shared publication - Elizabeth J Matey
Centre For Virus Research, Mbagathi Road Kenya Medical Research Institute, Nairobi, Kenya
1 shared publication - Francis A Plummer
National Microbiology Laboratories, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
1 shared publication - Joshua Kimani
UNITID
1 shared publication
Latest Publications
- Open Access
- 25 November 2010
- Published by Springer Nature in Virology Journal
- Vol. 7 (1) , 343
CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected Female sex workers
Design of effective vaccines against the human immunodeficiency virus (HIV-1) continues to present formidable challenges. However, individuals who are exposed HIV-1 but do not get infected may reveal correlates of protection that may inform on effective vaccine design. A preliminary gene expression analysis of HIV resistant female sex workers (HIV-R) suggested a high expression CD26/DPPIV gene. Previous studies have indicated an anti-HIV effect of high CD26/DPPIV expressing cells in vitro. Similarly, high CD26/DPPIV protein levels in vivo have been shown to be a risk factor for type 2 diabetes. We carried out a study to confirm if the high CD26/DPPIV gene expression among the HIV-R were concordant with high blood protein levels and its correlation with clinical type 2 diabetes and other perturbations in the insulin signaling pathway.
- 25 November 2010
- Published by Springer Nature in Virology Journal
- Vol. 7 (1) , 343
Open AccessCD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected Female sex workers
Design of effective vaccines against the human immunodeficiency virus (HIV-1) continues to present formidable challenges. However, individuals who are exposed HIV-1 but do not get infected may reveal correlates of protection that may inform on effective vaccine design. A preliminary gene expression analysis of HIV resistant female sex workers (HIV-R) suggested a high expression CD26/DPPIV gene. Previous studies have indicated an anti-HIV effect of high CD26/DPPIV expressing cells in vitro. Similarly, high CD26/DPPIV protein levels in vivo have been shown to be a risk factor for type 2 diabetes. We carried out a study to confirm if the high CD26/DPPIV gene expression among the HIV-R were concordant with high blood protein levels and its correlation with clinical type 2 diabetes and other perturbations in the insulin signaling pathway.